ArticleInternational journal of chronic obstructive pulmonary disease2025
Validation and Application of the Simplified Chinese Version of the Dyspnea-12 Questionnaire: An Independent Predictor for Hospitalization Risk in Chronic Obstructive Pulmonary Disease.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Construction and Validation of a Machine Learning Model Based on Clinical and Microbiomic Features for Predicting High Mucus Secretion in COPD.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Introduction: The Dyspnea-12 is a brief patient reported tool assessing physical and emotional components of breathlessness. However, the reliability and effectiveness of the Chinese version of Dyspnea-12 (D-12-C) needs to be verified. Purpose: This study aimed to assess the reliability and validity of D-12-C in patients with chronic obstructive pulmonary disease (COPD) and investigate its associations with clinical outcomes of COPD. Patients and Methods: Patients from three centers completed baseline assessments (pulmonary function test, the COPD Assessment Test (CAT), the Modified Medical Research Council Dyspnea Scale (mMRC), the Hospital Anxiety and Depression Scale (HADS), St George's Respiratory Questionnaire (SGRQ), Borg dyspnea scale, 6-minute walking distance (6MWD) and the history of exacerbations. The internal consistency, construct validity, convergent validity and reliability of the D-12-C were evaluated. The binary multivariate logistic regression analysis was performed to explore the influencing factors for hospitalization during follow-up. Results: A total of 279 patients were recruited. Exploratory factor analysis divided the D-12-C into physical and affective dimensions. A high level of internal consistency was manifested by the Cronbach's alpha values of the D-12-C with total scores, physical, and affective dimensions of 0.94, 0.96, and 0.92, respectively. The score of D-12-C increased as the GOLD or mMRC grade rose, and patients suffering from anxiety or depression had more severe dyspnea. The score of D-12-C was significantly correlated with CAT, mMRC, HADS, SGRQ and hospitalization during follow-up. Additionally, baseline D-12-C was an independent predictor of hospitalization during the one year follow-up (OR=1.086, 95% CI: 1.035-1.139, p < 0.001). Conclusion: The D-12-C demonstrated good internal consistency and validity in COPD. The score of D-12-C correlates with the clinical parameters of disease severity and predicts severe exacerbations of hospitalization, supporting its use in risk stratification and management planning to prevent adverse outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.